Remote Monitoring of Cardiac Mechanics in Heart Failure Patients

Condition(s) studied

Investigational drug(s) / intervention(s)

Continuous monitroing: Continuous monitoring for 30 days with a small combined SCG and 1-lead ECG sensor

Study summary

Heart failure is a severe heart disease, where the heart's ability to pump blood is unsatisfactory. The consequence is a high risk of hospitalization and death. Heart failure is treated with medicine which relieves symptoms and slows down the disease progression. This medical treatment needs routine adjustment, but in many cases, this adjustment is not done timely, which results in life treating conditions where the patients need acute hospitalization. Remote health monitoring of HF patients has the potential to ensure timely adjustment. However, only sensors placed inside the blood vessels of the lung, have been shown effective. The disadvantage is that the placement of the sensor requires surgery. This makes the method costly and poses a risk for the patient. The aim of the current project is to develop a small intelligent patch, which can measure the heart's function from the outside of the body. The method will be low-cost, simple to use and will not pose a risk to the patient.

Eligibility

Primary outcome measure(s)

• Rate of Heart Failure Related Hospitalization — Within 60 days of enrollment
  It will during the study be noted if an enrolled participant is hospitalized due to an alteration in heart failure condition.

Trial sites (2)

More Aalborg University trials in Denmark

Other trials for the same condition